Jacobs Levy Equity Management, Inc Acadia Pharmaceuticals Inc Transaction History

Jacobs Levy Equity Management, Inc

$23.9 Billion
Q1 2025

A detailed history of Jacobs Levy Equity Management, Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,977,432 shares of ACAD stock, worth $46 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

1,977,432

Previous 1,138,704 73.66%

Holding current value

$46 Million

Previous $20.9 Million 57.19%

% of portfolio

0.14%

Previous 0.08%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$16.61 - $20.29 $13.9 Million - $17 Million	838,728 Added 73.66%	1,977,432 $32.8 Million
Q4 2024 Feb 14, 2025	SELL	$14.29 - $18.76 $1.04 Million - $1.36 Million	-72,610 Reduced 5.99%	1,138,704 $20.9 Million
Q3 2024 Nov 14, 2024	SELL	$15.14 - $19.14 $2.18 Million - $2.75 Million	-143,688 Reduced 10.6%	1,211,314 $18.6 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $19.8 Million - $25 Million	1,355,002 New	1,355,002 $22 Million
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $27.4 Million - $41.9 Million	-1,319,007 Reduced 92.6%	105,396 $3.3 Million
Q3 2023 Nov 16, 2023	SELL	$20.84 - $33.47 $8.58 Million - $13.8 Million	-411,615 Reduced 22.42%	1,424,403 $29.7 Million
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $824,763 - $1.19 Million	-46,335 Reduced 2.46%	1,836,018 $44 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $3.97 Million - $5.09 Million	243,170 Added 14.83%	1,882,353 $35.4 Million
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $7.85 Million - $10.3 Million	552,681 Added 50.87%	1,639,183 $26.1 Million
Q3 2022 Nov 15, 2022	BUY	$14.11 - $18.27 $15.3 Million - $19.9 Million	1,086,502 New	1,086,502 $17.8 Million
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $7.67 Million - $16.1 Million	-589,726 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $1.02 Million - $1.34 Million	48,664 Added 8.99%	589,726 $14.3 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $517,702 - $835,293	30,834 Added 6.04%	541,062 $12.6 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $8.05 Million - $12.6 Million	510,228 New	510,228 $8.48 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $365,593 - $516,729	-18,845 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $471,501 - $1.04 Million	18,845 New	18,845 $486,000

Others Institutions Holding ACAD

# of Institutions

353

Shares Held

163M

Call Options Held

1.77M

Put Options Held

307K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Acadia Pharmaceuticals Inc Transaction History